Tom Wilemon Archive — Page 6 of 39
-
November 4, 2024
Tae Kon Kim receives V Foundation grant for MDS drug research
Kim and colleagues will study whether this protein hinders the ability of the immune system to fight MDS and whether it can be blocked to treat MDS. -
October 30, 2024
Michael Gibson votes with FDA panel to limit immunotherapy indication
The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival. -
October 24, 2024
Same day appointments can be made for mammograms
No referral from a primary care provider is required to book an appointment for a screening mammogram, but you must already have a medical chart set up at VUMC for the same-day service. -
October 22, 2024
Scott Zuckerman receives Credo Award for communication and commitment to colleagues
"The care we deliver in surgery is simply not possible without this army of devoted individuals.” -
October 15, 2024
Cathy Eng named Vanderbilt-Ingram Cancer Center associate director of Strategic Relations and Research Partnerships
Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies. -
October 7, 2024
New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage
Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.